SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q4 2022$624,668
+48.0%
10,1210.0%0.01%
+57.1%
Q3 2022$422,000
-48.5%
10,121
-66.7%
0.01%
-56.2%
Q1 2022$820,000
+110.8%
30,432
+49.8%
0.02%
+60.0%
Q4 2021$389,000
-51.6%
20,311
-16.5%
0.01%
-33.3%
Q3 2021$804,00024,3110.02%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 923,221$30,632,0005.64%
Sandhill Capital Partners LLC 1,429,432$47,429,0003.70%
Bullseye Asset Management LLC 117,471$3,898,0001.31%
Taylor Wealth Management Partners 72,685$2,412,0000.85%
Signature Wealth Management Partners, LLC 14,000$465,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 369,259$12,252,0000.40%
Triumph Capital Management 20,051$622,0000.36%
EMERALD ADVISERS, LLC 300,464$9,969,0000.36%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,347$2,533,0000.30%
Bellevue Group AG 729,989$24,221,0000.24%
View complete list of TRANSMEDICS GROUP INC shareholders